Nurix Therapeutics, Inc. · NASDAQ:NRIX

Hansen Gwenn sold 5,394 Nurix Therapeutics, Inc. shares (Form 4)

Traded Jun 25, 2026 · Filed Jun 25, 2026

On Jun 25, 2026, Hansen Gwenn (Chief Scientific Officer) sold 5,394 Nurix Therapeutics, Inc. shares at US$20.00 for US$108K under a trading plan, leaving 115,005 shares. Filed Jun 25, 2026 (Form 4).

Sold
5,394 shares
Price
US$20.00
Value
US$108K
Holding after
115,005 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Chief Scientific Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jun 25, 2026Common StockSale5,394US$20.00115,005Direct

Source

View original at SEC

Related